age related vision dysfunction epidemiology forecast insight

DelveInsight’s ‘Age-related Vision Dysfunction - Epidemiology Forecast to 2034’ report delivers an in-depth understanding of the disease, historical and forecasted Age-related Vision Dysfunction epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Geography Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2021-2034

Age-related Vision Dysfunction Understanding

The International Classification of Diseases 11 (2018) classifies vision impairment into two groups, distance and near presenting vision impairment. Beginning in the early to mid-forties, most adults may start to experience problems with their ability to see clearly at close distances, especially for reading and computer tasks. This normal change in the eye’s focusing ability will continue to progress over time. Vision loss among the elderly population is a major health care problem. Approximately one in three people have some form of vision-reducing eye disease by the age of 65. Beginning in the early to mid-forties, most adults may start to experience problems with their ability to see clearly at close distances, especially for reading and computer tasks. This normal change in the eye’s focusing ability will continue to progress over time. Adults over 40 may be particularly at risk for the development of eye and vision problems.

The process of aging contributes to visual loss through the deterioration of the function of the eye tissues and increased ocular pathology in the elderly. The process of pathology takes place over months to years, and patients usually have minimal symptoms initially. The five major causes of visual impairment in the elderly are presbyopia, age-related cataracts, age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy, and the same set of indications we have taken forward for the epidemiology and market estimation.

Aging changes in various parts of the eye can result in several noticeable differences in how well a person can see. While not everyone will experience the same level of symptoms, the following are common age-related vision changes, some of the common symptoms include difficulty reading and doing close work, problems with glare, changes in color perception, reduced tear production, seeing distorted images, loss of side vision, seeing floaters and flashes, and fluctuating vision.

Age-related Vision Dysfunction Diagnosis 

The comprehensive adult eye and vision examination provides the means to evaluate the function and health of the eyes and visual system and to obtain information to diagnose the cause of signs noted by the examiner or symptoms reported by the patient. It also provides the means to identify the presence of other ocular or systemic conditions that may exist without symptoms.

The diagnostic tests for the various vision diseases caused by old age include tests such as visual acuity tests, Fundus Fluorescein Angiography (FFA), Indocyanine green angiography (ICG), Amsler Grid Test, Visual Field Test, and Tonometry Test, among others.

Epidemiology Perspective by DelveInsight

The Age-related Vision Dysfunction epidemiology division provides insights about historical and current Age-related Vision Dysfunction patient pool and forecasted trends for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

In the year 2020, the total prevalent case of Age-related Vision Dysfunction was 374,306,439 cases in the 7MM which are expected to grow during the study period, i.e., 2021-2034.

The disease epidemiology covered in the report provides historical as well as forecasted Age-related Vision Dysfunction epidemiology [segmented as Total Prevalent Cases of Age-related Vision Dysfunction, Total Diagnosed Cases of Age-related Vision Dysfunction, Severity-specific Cases of Age-related Vision Dysfunction, and Treated cases of Age-related Vision Dysfunction] in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2021 to 2034.

Country Wise- Age-related Vision Dysfunction Epidemiology

Estimates show that the highest cases of Age-related Vision Dysfunction in the 7MM were in the United States, followed by Japan, Germany, Italy, France, the United Kingdom, and Spain in 2020.

• In the United States, the total number of prevalent cases of Age-related Vision Dysfunction was 159,952,427 cases in the year 2020 which are expected to grow during the study period, i.e., 2021-2034.
• In the year 2020, the total prevalent cases of Age-related Vision Dysfunction were 168,408,889 cases in EU-5 which are expected to grow during the study period, i.e., 2021-2034.
• In Japan, the total number of prevalent cases of Age-related Vision Dysfunction was 45,945,123 cases in the year 2020 which are expected to grow during the study period, i.e., 2021-2034.

Scope of the Report

• The Age-related Vision Dysfunction report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns.
• The Age-related Vision Dysfunction Report and Model provide an overview of the risk factors and global trends of Age-related Vision Dysfunction in the seven major markets (7MM: The United States, Germany, France, Italy, Spain, and the United Kingdom, and Japan)
• The report provides insight about the historical and forecasted patient pool of Age-related Vision Dysfunction in seven major markets covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
• The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
• The report assesses the disease risk and burden and highlights the unmet needs of Age-related Vision Dysfunction.
• The report provides the segmentation of the Age-related Vision Dysfunction epidemiology by total prevalent cases in the 7MM.
• The report provides the segmentation of the Age-related Vision Dysfunction epidemiology by total diagnosed cases in the 7MM.
• The report provides the segmentation of the Age-related Vision Dysfunction epidemiology by severity-specific cases in the 7MM.
• The report provides the segmentation of the Age-related Vision Dysfunction epidemiology by treated cases in the 7MM.

Report Highlights

• 10-Year Forecast of Age-related Vision Dysfunction epidemiology
• 7MM Coverage
• Total Prevalent Cases of Age-related Vision Dysfunction
• Total Diagnosed Cases of Age-related Vision Dysfunction
• Severity-specific Cases of Age-related Vision Dysfunction
• Treated Cases of Age-related Vision Dysfunction

KOL-Views 

We interview KOL’s and SME's opinions through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM concerning the patient population of Age-related Vision Dysfunction?
• What are the key findings of the Age-related Vision Dysfunction epidemiology across the 7MM and which country will have the highest number of patients during the study period (2021-2034)?
• What would be the total number of patients with Age-related Vision Dysfunction across the 7MM during the study period (2021-2034)?
• Among the EU5 countries, which country will have the highest number of patients during the study period (2021-2034)?
• At what CAGR the patient population is expected to grow in the 7MM during the study period (2021-2034)?
• What are the various recent and upcoming events which are expected to improve the diagnosis of Age-related Vision Dysfunction?

Reasons to buy

The Age-related Vision Dysfunction Epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Age-related Vision Dysfunction market
• Quantify patient populations in the global Age-related Vision Dysfunction market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the gender that presents the best opportunities for Age-related Vision Dysfunction therapeutics in each of the markets covered
• Understand the magnitude of Age-related Vision Dysfunction population by its severity
• The Age-related Vision Dysfunction epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists
• The Age-related Vision Dysfunction Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population